.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Teva
Argus Health
Farmers Insurance
Boehringer Ingelheim
Mallinckrodt
Cipla
Healthtrust
Dow
Johnson and Johnson

Generated: December 13, 2017

DrugPatentWatch Database Preview

DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Doxylamine Succinate And Pyridoxine Hydrochloride, and when can generic versions of Doxylamine Succinate And Pyridoxine Hydrochloride launch?

Doxylamine Succinate And Pyridoxine Hydrochloride is a drug marketed by Actavis Labs Fl Inc and is included in one NDA.

The generic ingredient in DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE is doxylamine succinate; pyridoxine hydrochloride. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the doxylamine succinate; pyridoxine hydrochloride profile page.

Summary for DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE

Drug patent expirations by year for DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl IncDOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDEdoxylamine succinate; pyridoxine hydrochlorideTABLET, DELAYED RELEASE;ORAL205811-001Aug 19, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
UBS
McKesson
Boehringer Ingelheim
US Army
Novartis
Colorcon
Cerilliant
Chinese Patent Office
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot